Amprenavir

Chemical formula: C₂₅H₃₅N₃O₆S  Molecular mass: 505.627 g/mol  PubChem compound: 65016

Active ingredient description

Amprenavir is a competitive inhibitor of HIV-1 protease. Amprenavir binds to the active site of HIV-1 protease and thereby prevents the processing of viral gag and gag-pol polyprotein precursors, resulting in the formation of immature non-infectious viral particles.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC Group Classification
J05AE05 Amprenavir J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AE Protease inhibitors
Discover more medicines within J05AE05

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 161814-49-9
DrugBank Drug: DB00701
KEGG Drug: D00894
PubChem Compound: 65016
RxNorm Ingredient: 228656
SNOMED-CT Concept: 387006009
Amprenavir (substance)
UNII Identifier: 5S0W860XNR
AMPRENAVIR
 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈